Literature DB >> 25006189

Recommended patient-reported core set of symptoms to measure in head and neck cancer treatment trials.

Bhishamjit S Chera1, Avraham Eisbruch2, Barbara A Murphy2, John A Ridge2, Patrick Gavin2, Bryce B Reeve2, Deborah Watkins Bruner2, Benjamin Movsas2.   

Abstract

We identified a standard core set of patient-reported symptoms and health-related quality-of-life (HRQOL) domains to be assessed in head and neck (H&N) cancer clinical trials. The core symptom and HRQOL domain scores were used to guide recommendations by a working group of experts as part of a National Cancer Institute Symptom Management and HRQOL Clinical Trials Planning Meeting. A PubMed search was conducted using the search terms of "health-related quality of life" and "head & neck cancer," limited to publications from January 1, 2000, to December 31, 2010. Fifty-four articles were used to guide the choice of recommendations. Twenty-nine symptoms and nine domains were identified, from which 12 H&N-specific core symptoms and HRQOL domains were recommended: swallowing, oral pain, skin changes, dry mouth, dental health, opening mouth/trismus, taste, excess/thick mucous/saliva, shoulder disability/motion, voice/hoarseness, social domain, and functional domain. This core set of 12 H&N-specific, patient-reported symptoms and HRQOL domains should be assessed in future H&N cancer clinical trials.
© The Author 2014. Published by Oxford University Press. All rights reserved.

Entities:  

Mesh:

Year:  2014        PMID: 25006189      PMCID: PMC4192043          DOI: 10.1093/jnci/dju127

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  12 in total

1.  Human papillomavirus and survival of patients with oropharyngeal cancer.

Authors:  K Kian Ang; Jonathan Harris; Richard Wheeler; Randal Weber; David I Rosenthal; Phuc Felix Nguyen-Tân; William H Westra; Christine H Chung; Richard C Jordan; Charles Lu; Harold Kim; Rita Axelrod; C Craig Silverman; Kevin P Redmond; Maura L Gillison
Journal:  N Engl J Med       Date:  2010-06-07       Impact factor: 91.245

Review 2.  Quality of life research in head and neck cancer: a review of the current state of the science.

Authors:  Barbara A Murphy; Sheila Ridner; Nancy Wells; Mary Dietrich
Journal:  Crit Rev Oncol Hematol       Date:  2007-04-03       Impact factor: 6.312

3.  Underreporting by cancer patients: the case of response-shift.

Authors:  I S Breetvelt; F S Van Dam
Journal:  Soc Sci Med       Date:  1991       Impact factor: 4.634

4.  Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial.

Authors:  Carole Fakhry; William H Westra; Sigui Li; Anthony Cmelak; John A Ridge; Harlan Pinto; Arlene Forastiere; Maura L Gillison
Journal:  J Natl Cancer Inst       Date:  2008-02-12       Impact factor: 13.506

5.  Incidence trends for human papillomavirus-related and -unrelated oral squamous cell carcinomas in the United States.

Authors:  Anil K Chaturvedi; Eric A Engels; William F Anderson; Maura L Gillison
Journal:  J Clin Oncol       Date:  2008-02-01       Impact factor: 44.544

6.  Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer.

Authors:  Marshall R Posner; Diane M Hershock; Cesar R Blajman; Elizabeth Mickiewicz; Eric Winquist; Vera Gorbounova; Sergei Tjulandin; Dong M Shin; Kevin Cullen; Thomas J Ervin; Barbara A Murphy; Luis E Raez; Roger B Cohen; Monica Spaulding; Roy B Tishler; Berta Roth; Rosana del Carmen Viroglio; Varagur Venkatesan; Ilya Romanov; Sanjiv Agarwala; K William Harter; Matthew Dugan; Anthony Cmelak; Arnold M Markoe; Paul W Read; Lynn Steinbrenner; A Dimitrios Colevas; Charles M Norris; Robert I Haddad
Journal:  N Engl J Med       Date:  2007-10-25       Impact factor: 91.245

7.  Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival.

Authors:  James A Bonner; Paul M Harari; Jordi Giralt; Roger B Cohen; Christopher U Jones; Ranjan K Sur; David Raben; Jose Baselga; Sharon A Spencer; Junming Zhu; Hagop Youssoufian; Eric K Rowinsky; K Kian Ang
Journal:  Lancet Oncol       Date:  2009-11-10       Impact factor: 41.316

Review 8.  Recommended patient-reported core set of symptoms to measure in adult cancer treatment trials.

Authors:  Bryce B Reeve; Sandra A Mitchell; Amylou C Dueck; Ethan Basch; David Cella; Carolyn Miller Reilly; Lori M Minasian; Andrea M Denicoff; Ann M O'Mara; Michael J Fisch; Cynthia Chauhan; Neil K Aaronson; Corneel Coens; Deborah Watkins Bruner
Journal:  J Natl Cancer Inst       Date:  2014-07-08       Impact factor: 13.506

9.  Factors associated with severe late toxicity after concurrent chemoradiation for locally advanced head and neck cancer: an RTOG analysis.

Authors:  Mitchell Machtay; Jennifer Moughan; Andrew Trotti; Adam S Garden; Randal S Weber; Jay S Cooper; Arlene Forastiere; K Kian Ang
Journal:  J Clin Oncol       Date:  2008-06-16       Impact factor: 44.544

10.  TAME: development of a new method for summarising adverse events of cancer treatment by the Radiation Therapy Oncology Group.

Authors:  Andy Trotti; Thomas F Pajak; Clement K Gwede; Rebecca Paulus; Jay Cooper; Arlene Forastiere; John A Ridge; Deborah Watkins-Bruner; Adam S Garden; K Kian Ang; Wally Curran
Journal:  Lancet Oncol       Date:  2007-07       Impact factor: 41.316

View more
  24 in total

1.  The impact of taste and smell alterations on quality of life in head and neck cancer patients.

Authors:  M Alvarez-Camacho; S Gonella; S Ghosh; C Kubrak; R A Scrimger; K P Chu; W V Wismer
Journal:  Qual Life Res       Date:  2015-11-20       Impact factor: 4.147

2.  Development of a survivorship needs assessment planning tool for head and neck cancer survivors and their caregivers: a preliminary study.

Authors:  K R Sterba; J Zapka; N LaPelle; T K Garris; A Buchanan; M Scallion; T Day
Journal:  J Cancer Surviv       Date:  2017-06-21       Impact factor: 4.442

3.  Performance Measures Based on How Adults With Cancer Feel and Function: Stakeholder Recommendations and Feasibility Testing in Six Cancer Centers.

Authors:  Angela M Stover; Benjamin Y Urick; Allison M Deal; Randall Teal; Maihan B Vu; Jessica Carda-Auten; Jennifer Jansen; Arlene E Chung; Antonia V Bennett; Anne Chiang; Charles Cleeland; Yehuda Deutsch; Edmund Tai; Dylan Zylla; Loretta A Williams; Collette Pitzen; Claire Snyder; Bryce Reeve; Tenbroeck Smith; Kristen McNiff; David Cella; Michael N Neuss; Robert Miller; Thomas M Atkinson; Patricia A Spears; Mary Lou Smith; Cindy Geoghegan; Ethan M Basch
Journal:  JCO Oncol Pract       Date:  2020-02-19

4.  Leveraging patient-reported outcomes data to inform oncology clinical decision making: Introducing the FACE-Q Head and Neck Cancer Module.

Authors:  Jennifer R Cracchiolo; Anne F Klassen; Danny A Young-Afat; Claudia R Albornoz; Stefan J Cano; Snehal G Patel; Andrea L Pusic; Evan Matros
Journal:  Cancer       Date:  2018-11-30       Impact factor: 6.860

5.  Testing Symptom Severity Thresholds and Potential Alerts for Clinical Intervention in Patients With Cancer Undergoing Chemotherapy.

Authors:  Qiuling Shi; Ju-Whei Lee; Xin Shelley Wang; Michael J Fisch; Victor T Chang; Lynne Wagner; Charles S Cleeland
Journal:  JCO Oncol Pract       Date:  2020-05-05

6.  What Are We Really Measuring? A Content Comparison of Swallowing Outcome Measures for Head and Neck Cancer Based on the International Classification of Functioning, Disability and Health (ICF).

Authors:  Rebecca Louise Nund; Bena Brown; Elizabeth Celeste Ward; Julia Maclean; Justin Roe; Joanne M Patterson; Rosemary Martino
Journal:  Dysphagia       Date:  2019-04-03       Impact factor: 3.438

7.  Implementation of Symptom Questionnaires Into Oncology Workflow.

Authors:  Angela M Stover; Ethan M Basch
Journal:  J Oncol Pract       Date:  2016-10       Impact factor: 3.840

8.  Phase II Trial of De-Intensified Chemoradiotherapy for Human Papillomavirus-Associated Oropharyngeal Squamous Cell Carcinoma.

Authors:  Bhishamjit S Chera; Robert J Amdur; Rebecca Green; Colette Shen; Gaorav Gupta; Xianming Tan; Mary Knowles; David Fried; Neil Hayes; Jared Weiss; Juneko Grilley-Olson; Shetal Patel; Adam Zanation; Trevor Hackman; Jose Zevallos; Jeffrey Blumberg; Samip Patel; Mohit Kasibhatla; Nathan Sheets; Mark Weissler; Wendell Yarbrough; William Mendenhall
Journal:  J Clin Oncol       Date:  2019-08-14       Impact factor: 44.544

9.  Health-related quality of life before and after head and neck squamous cell carcinoma: Analysis of the Surveillance, Epidemiology, and End Results-Medicare Health Outcomes Survey linkage.

Authors:  Eleni M Rettig; Gypsyamber D'Souza; Carol B Thompson; Wayne M Koch; David W Eisele; Carole Fakhry
Journal:  Cancer       Date:  2016-05-16       Impact factor: 6.860

Review 10.  Recommended patient-reported core set of symptoms to measure in adult cancer treatment trials.

Authors:  Bryce B Reeve; Sandra A Mitchell; Amylou C Dueck; Ethan Basch; David Cella; Carolyn Miller Reilly; Lori M Minasian; Andrea M Denicoff; Ann M O'Mara; Michael J Fisch; Cynthia Chauhan; Neil K Aaronson; Corneel Coens; Deborah Watkins Bruner
Journal:  J Natl Cancer Inst       Date:  2014-07-08       Impact factor: 13.506

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.